You're reading the free version. Trader adds the live tape and alerts.
Start tracking
VKTX Sale Disclosure
Zante Greg · SEC Form 4 · Filed Jul 29, 2026
Sale
Calculated transaction value
$710.14K
Zante Greg Chief Financial Officer
VKTX
Viking Therapeutics
VKTX
Transaction date
Jul 29, 2026
Public filing date
Jul 29, 2026
Filing lag
Filed same day
VKTX daily price context
Close on/before transaction
$33.43
Jul 29, 2026
First close after public filing
$33.11
Jul 30, 2026
30-day return after filing
-2.87%
Through Aug 28, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock, par value $0.00001 per share
- Quantity / price
- 21,217 shares @ $33.47
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001193125-26-324447
Filing cohort
Transactions in this filing
Showing 2 of 2
Trades
2
Issuers
1
Estimated value
$710.14K
Buys / sales
0 / 1
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Viking Therapeutics, Inc. VKTX Current | Sale | Jul 29, 2026 | $710.14K |
| Viking Therapeutics, Inc. VKTX | Award | Jul 28, 2026 | $0 |